Division of Neurosurgery, University of Arizona, Tucson, AZ, USA.
J Pain Res. 2014 Aug 12;7:465-70. doi: 10.2147/JPR.S66414. eCollection 2014.
Spinal cord stimulation (SCS) provides significant relief for lumbosacral radiculopathy refractory to both medical and surgical treatment, but historically only offers limited relief for axial low back pain (LBP). We aim to evaluate the response of chronic axial LBP treated with SCS using a surgically implanted epidural paddle lead.
This is a retrospective review of a consecutive series of patients with exclusive LBP or predominant LBP associated with lower extremity (LE) pain evaluated and treated with SCS using an implanted paddle lead within the dorsal thoracic epidural space. Baseline LBP, and if present LE pain, were recorded using the visual analogue scale (VAS) at an initial evaluation. At a follow-up visit (a minimum of 12 months later), LBP and LE pain after a spinal cord stimulator implantation were again recorded using the VAS. Patients were also asked to estimate total LBP pain relief achieved.
Patients with either exclusive (n=7) or predominant (n=2) axial LBP were treated with SCS by implantation of a paddle lead at an average spine level of T9. The baseline VAS score for LBP was 7.2; after a follow-up of 20 months, the score decreased to 2.3 (P=0.003). The LE pain VAS score decreased from 7.5 to 0.0 (P=0.103). Patients also reported a subjective 66.4% decrease of their LBP at follow-up. There were no surgical complications.
Axial LBP is refractory to many treatments, including SCS. SCS using a surgically implanted paddle electrode provides significant pain relief for chronic axial LPB, and is a safe treatment modality.
脊髓刺激(SCS)为腰椎神经根病提供了显著的缓解,这种疾病对药物和手术治疗都有抗性,但历史上仅对轴向下腰痛(LBP)提供有限的缓解。我们旨在评估使用外科植入的硬膜外桨状导联治疗慢性轴向 LBP 的反应。
这是对一系列连续的患者进行的回顾性研究,这些患者仅患有 LBP 或主要患有 LBP,伴或不伴有下肢(LE)疼痛,使用植入的硬膜外背部的桨状导联进行 SCS 评估和治疗。在初始评估时,使用视觉模拟量表(VAS)记录基线 LBP,如果存在,则记录 LE 疼痛。在随访就诊时(至少 12 个月后),再次使用 VAS 记录脊髓刺激器植入后的 LBP 和 LE 疼痛。还要求患者估计总 LBP 疼痛缓解程度。
7 名患者患有单纯性(n=7)或主要(n=2)轴向 LBP,通过在 T9 平均脊柱水平植入桨状导联进行 SCS 治疗。LBP 的基线 VAS 评分为 7.2;随访 20 个月后,评分降至 2.3(P=0.003)。LE 疼痛 VAS 评分从 7.5 降至 0.0(P=0.103)。患者还报告在随访时 LBP 主观下降了 66.4%。没有手术并发症。
轴向 LBP 对许多治疗方法都有抗性,包括 SCS。使用外科植入的桨状电极进行 SCS 可为慢性轴向 LBP 提供显著的疼痛缓解,是一种安全的治疗方式。